We follow industry news and trends so you can stay ahead of the game. Subscribe to receive emails regarding policies and findings that impact you and your business.

Already a subscriber and want to update your preferences? Click here.

BACK TO NEWS

MEDIA MENTIONS

SEP 27 2017

Pfizer, J&J Antitrust Suit Is Next Big Pharma Fight - Bloomberg BNA

William Garvin, Shareholder in the firm's FDA & Biotechnology practice, comments on the impact of biosimilars, lower-priced copies of expensive biotechnology drugs, in Bloomberg BNA's article "Pfizer, J&J Antitrust Suit Is Next Big Pharma Fight." Pfizer Inc.'s suit alleging Johnson & Johnson stopped a biosimilar is the first lawsuit of its kind.